| Literature DB >> 35924017 |
Xiaodan Jiang1,2, Yu Wan1,2, Hao Yuan1,2, Liming Zhao3, Min Sun4, Yanhui Xu5, Xiangyang Xin6, Jing Dong7, Die Hu8, Dongmei Chen9, Xuemin Li1,2.
Abstract
Objective: To investigate the incidence of acute postoperative endophthalmitis (POE) after cataract surgery in Northern China from 2013 to 2019, evaluate the efficacy of prophylaxis and analyze the predictors of visual prognosis among POE patients.Entities:
Keywords: cataract surgery; endophthalmitis; infection prophylaxis; prognosis predictors
Year: 2022 PMID: 35924017 PMCID: PMC9342430 DOI: 10.2147/IDR.S332997
Source DB: PubMed Journal: Infect Drug Resist ISSN: 1178-6973 Impact factor: 4.177
Incidence of Acute POE Among Different Years and Hospitals
| No. of Cataract Surgeries (n) | No. of Endophthalmitis (n) | Incidence of Endophthalmitis (95% CIs) | |
|---|---|---|---|
| 2013 | 7207 | 4 | 0.056% (0.001%, 0.110%) |
| 2014 | 8255 | 3 | 0.036% (0, 0.078%) |
| 2015 | 8925 | 3 | 0.034% (0, 0.072%) |
| 2016 | 10,684 | 4 | 0.037% (0.001%, 0.074%) |
| 2017 | 11,602 | 2 | 0.017% (0, 0.041%) |
| 2018 | 11,738 | 2 | 0.017% (0, 0.041%) |
| 2019 | 13,844 | 1 | 0.007% (0, 0.021%) |
| Mantel–Haenszel test: | |||
| A | 31951 | 8 | 0.025% (0.008%, 0.042%) |
| B | 31335 | 4 | 0.013% (0, 0.025%) |
| C | 2799 | 1 | 0.036% (0, 0.106%) |
| D | 2790 | 1 | 0.036% (0, 0.106%) |
| E | 454 | 0 | 0 |
| F | 2555 | 5 | 0.196% (0.024%, 0.367%) |
| G | 371 | 0 | 0 |
| 72,255 | 19 | 0.026% (0.015%, 0.038%) |
Note: ※Represents the p value for Mantel–Haenszel test was less than 0.05, which suggests the annual incidence of acute POE after cataract surgery changed over years.
Abbreviations: POE, postoperative endophthalmitis; CI, confidence interval.
Figure 1The trends of the incidence of acute POE (postoperative endophthalmitis) over years among different hospitals. The black arrow: time point when 5% PVP-I (povidone-iodine) started to be used in Hospital-A. The gray arrow: time point when 0.5% PVP-I started to be used in Hospital-F. “※” represents the p value for comparing the incidences of POE before and after the usage of PVP-I was less than 0.05, which suggests the incidence of postoperative endophthalmitis significantly decreased in Hospital-F after the application of 0.5% PVP-I.
Perioperative Infection Prophylaxis in Each of Hospitals
| Hospital-A | Hospital-B | Hospital-C | Hospital-D | Hospital-E | Hospital-F | Hospital-G | ||
|---|---|---|---|---|---|---|---|---|
| Topical antibiotics | 0.5% LVX | 0.5% LVX | 0.3% GAT | 0.5% LVX | 0.3%TOB | 0.5% LVX | 0.5% LVX | |
| Conjunctiva sac washing | 5% PVP-I (2017–2019) | 5% PVP-I | 0.5%PVP-I | 0.5%PVP-I | 0.5% PVP-I | 0.5% PVP-I (2016–2019) | 0.1%PVP-I | |
| Antibiotics in irrigation solutions | — | TOB 4mg/1000mL※ | — | — | TOB 8mg/1000mL※ | — | — | |
| Intracameral antibiotics | — | — | — | — | — | — | — | |
| Subconjunctival antibiotics | — | — | — | — | — | — | — | |
| Ophthalmic ointment | 0.3%TOB+ | 0.3%TOB+ | 0.3%TOB+ | 0.3%TOB+ | 0.3%TOB+ | 0.3%TOB+ | 0.3%TOB+ | |
| Topical antibiotics | 0.5% LVX | 0.5% LVX | 0.3%GAT | 0.3%TOB | 0.3%TOB | 0.5% LVX | 0.3%TOB | |
| 0.025% | 0.013% | 0.036% | 0.036% | 0 | 0.196% | 0 | ||
Note: ※Represents that Hospital-B and E adopted tobramycin in the irrigation solution and achieved a significant lower incidence than the other hospitals where no antibiotics were administrated in the irrigation solution (p = 0.044).
Abbreviations: LVX, levofloxacin; TOB, tobramycin; DEX, dexamethasone; GAT, gatifloxacin; PVP-I, povidone-iodine; POE, postoperative endophthalmitis.
Analysis of Potential Prognostic Factors for Final Visual Outcome in POE Patients
| Predictors | Number of Cases (n) | Unfavorable Vision (n) | ||
|---|---|---|---|---|
| Sex | Male | 9 | 5 | 0.838 |
| Female | 6 | 3 | ||
| Age | ≤70 years | 8 | 6 | 0.082 |
| >70 years | 7 | 2 | ||
| DM | With DM | 8 | 5 | 0.462 |
| Without DM | 7 | 3 | ||
| Time to onset | ≤7 days | 12 | 7 | 0.453 |
| >7 days | 3 | 1 | ||
| Presenting BCVA | CF or better | 3 | 0 | 0.046※ |
| HM or worse | 12 | 8 | ||
| Antibiotics | Combined antibiotics (V+C) | 7 | 4 | 0.789 |
| Single antibiotics (V) | 8 | 4 | ||
| PPV | PPV performed | 6 | 4 | 0.414 |
| No PPV | 9 | 4 | ||
| Culture | Positive | 3 | 2 | 0.626 |
| Negative | 10 | 5 | ||
Note: ※Represents the p value for analysis of prognostic factors was less than 0.05, suggests that patients with presenting BCVA of CF or better were less likely to present with unfavorable final vision than those with presenting BCVA of HM or worse.
Abbreviations: POE, postoperative endophthalmitis; DM, diabetes mellitus; BCVA, best corrected visual acuity; CF, counting fingers; HM, hand motions; V, vancomycin; C, ceftazidime; PPV, pars plana vitrectomy.